VExUS-guided Fluid Management in Patients With Acute Kidney Injury in the Intensive Care Unit
VExUS-guided Fluid Management in Patients With Acute Kidney Injury in the Intensive Care Unit
A quasi experimental study that aims to verify whether the incorporation of VExUS in patients with AKI in the Intensive Care Unit (ICU) may prompt tailored interventions to increases the number of days free from Renal Replacement Therapy (RRT) during the first 28 days.
Fluid overload is associated with organ dysfunction, such as Acute Kidney Injury (AKI), and increased mortality. It remains unclear if fluid overload is merely an epiphenomenon in critically ill patients or if organ congestion is a mediator of complications. Considering AKI related to fluid overload, diuretic therapy would reduce venous congestion and improve renal blood flow. The Venous Excess Ultrasound score (VExUS) identifies clinically significant venous congestion and indicates a high risk of post-operative AKI. This quasi-experimental study aims to verify whether the incorporation of VExUS in patients with AKI in the Intensive Care Unit (ICU) may prompt tailored interventions to increases the number of days free from Renal Replacement Therapy (RRT) during the first 28 days.
Inclusion Criteria:
Exclusion Criteria:
mboniatti@hcpa.edu.br+55 (51) 3359.8000
marcosrihl@gmail.com+55 (51) 3359.8000
Porto Alegre, Rio Grande do Sul 90035-903, Brazil
mboniatti@hcpa.edu.br+55 (51) 3359.8000
marcosrihl@gmail.com+55 (51) 3359.8000